November 18, 2015
1 min read
Save

DaVita's Lifeline Vascular Access under federal investigation for possible false claims

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A DaVita HealthCare Partners subsidiary is under federal investigation for possible violation of the False Claims Act. RMS Lifeline Inc., which does business under the name Lifeline Vascular Access, has received a civil investigative demand from the Justice Department relating to two vascular access centers it operates in Florida. The department is conducting a False Claims Act investigation and is reviewing the medical necessity of angiograms performed on 10 patients, covering a period from Jan. 1, 2008 through the present, according to DaVita's Nov. 18 filing with the U.S. Securities and Exchange Commission.

Read also: Court finds Fresenius did not violate False Claims Act in overfill case

"The company maintains policies and procedures to promote compliance with the False Claims Act and other applicable laws and regulations, and intends to cooperate with the government," DaVita said in the form. "The company cannot predict, however, when this investigation will be resolved, its eventual outcome or scope, or its potential impact on the company." -by Rebecca Zumoff